Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 24 clinical trials
Eltrombopag for Patients With Fanconi Anemia

To find out if a new drug, eltrombopag, is effective in people with Fanconi anemia. To know how long the drug needs to be given to improve blood counts.

eltrombopag
neutrophil count
cytopenia
platelet count
chromosome breakage
  • 166 views
  • 19 Sep, 2022
  • 1 location
Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

attacking the bone marrow. However, this treatment does not work in all people. Some people still have poor blood cell counts even after treatment. Eltrombopag is a drug designed to mimic a

immunosuppression
eltrombopag
blood disorder
anemia
aplastic anemia
  • 115 views
  • 21 Apr, 2022
  • 1 location
Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CART

marrow damage and lack of recovery of blood counts after treatment. In this study, patients with prolong aplasia after CAR-T will recieve eltrombopag to enahnce bone marrow recovery.

neutrophil count
cytopenia
multiple myeloma
cancer chemotherapy
  • 0 views
  • 01 May, 2022
  • 1 location
Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors

Primary Objective: To assess safety of eltrombopag in pediatric patients undergoing intensive chemotherapy for malignant solid tumors. Secondary Objectives: To assess the efficacy of

  • 0 views
  • 02 Aug, 2021
  • 1 location
Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)

The aim of this study is to improve treatment of Moderate Aplastic Anemia (MAA) by evaluating the safety and efficiency of Eltrombopag as a new treatment option in patients with therapy

eltrombopag
aplastic anemia
neutrophil count
platelet count
blood transfusion
  • 78 views
  • 22 Jan, 2021
  • 1 location
Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

This is an investigator initiated, multicenter, open label, randomized phase 3 study for subjects with newly diagnosed ITP from ages 1 to less than 18 years old.

immune globulin
eltrombopag
autoimmune thrombocytopenia
platelet count
intravenous immunoglobulin
  • 22 views
  • 06 Feb, 2022
  • 11 locations
Eltrombopag Combined With Low-dose Rituximab in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

This prospective, open-label, nonrandomized, multicenter clinical trial aims at comparing the efficacy and safety of combined use of eltrombopag with low-dose rituximab vs. the best available

immune globulin
eltrombopag
glucocorticoids
evans syndrome
rituximab
  • 0 views
  • 26 May, 2022
  • 1 location
A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP (XPAG-ITP)

The purpose of this study is to compare the ability of eltrombopag in combination with a short course of high-dose dexamethasone to induce sustained response off treatment in patients with newly

eltrombopag
dexamethasone
platelet count
  • 20 views
  • 07 Jul, 2022
  • 23 locations
RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation: a Prospective, Phase II Study by the SFGM-TC (REGALIA)

transplantation. The aim objective of the investigator's study is to demonstrate that eltrombopag improve PGF after allo-HCT

thrombocytopenia
anemia
cell transplantation
myelodysplasia
graft versus host disease
  • 0 views
  • 20 Sep, 2022
  • 1 location
Prospective, Multi-center, Open-label Study Measuring Safety and Treatment Satisfaction in Adult Subjects With Chronic Immune Thrombocytopenia (ITP) After Switching to Avatrombopag From Eltrombopag or Romiplostim

Evaluate the safety and tolerability of avatrombopag given for 90 days after stopping treatment with eltrombopag or romiplostim.

thrombocytopenia
eltrombopag
romiplostim
avatrombopag
  • 0 views
  • 18 Sep, 2022
  • 13 locations